Its support to Tata Trusts Cancer Care programme since 2020 has helped in enrolling and screening 70,000 people for non-communicable diseases (NCDs) and Cancer across Assam, Jharkhand and Andhra Pradesh, according to Pfizer.
Pfizer partnered with Tata Trusts’ Special Purpose Vehicle, Alamelu Charitable Foundation (ACF) for their Cancer Care Programme to help set up health and wellness kiosks, facilitate community screening and a virtual patient helpdesk, and assist in the training of ASHA and Anganwadi workers in Diphu and Silchar in Assam and, additionally, in Ranchi, Jharkhand, and Tirupati, Andhra Pradesh. The partnership initiatives underway in Diphu and Silchar in Assam, Ranchi in Jharkhand, and Tirupati in Andhra Pradesh, comprised of these initiatives – Health and Wellness Kiosks, Virtual patient helpdesks, Community Outreach, Patient referral and tracking platform.
As Assam has one of the highest rates of new cancer cases in India, the objective of the partnership is to help bring down the high burden of cancer by raising awareness, aiding in early detection of cancer, and, through several programmes, serving the public, patients and caregivers support through the cancer treatment journey.
